Table 3.

Serum and Whole Blood Glucose Levels at Baseline and After the 12-Week Intervention

	Placebo (n=20)		Test (n=21)
	Baseline	Week 12	Baseline	Week 12
Serum glucose (mg/dL)
Glu_0 min	109.75±3.57	107.95±4.39	110.57±3.50	107.43±4.66
Glu_30 min	184.75±8.09	180.85±8.68	208.90±11.53	186.67±8.95*
Glu_60 min	195.10±14.51	195.85±14.38	216.14±15.45	210.52±14.97
Glu_120 min	158.15±16.95	165.45±17.38	163.24±11.53	166.52±20.62
Glu_AUC (mg/dL×h)	345.30±22.55	347.10±23.38	375.86±19.92	361.43±26.32
Whole blood glucose (mg/dL)
Glu_0 min	128.40±3.44	124.80±4.51	127.90±3.50	122.33±4.85†
Glu_30 min	203.05±7.83	195.25±8.13	217.29±6.48	199.76±8.38**
Glu_60 min	204.65±13.46	212.80±12.18	230.90±13.87	219.95±13.23
Glu_120 min	177.00±16.11	174.45±14.88	179.62±12.31	179.14±18.70
Glu_AUC (mg/dL×h)	375.75±20.90	375.70±20.79	403.86±17.94	385.19±23.60†

Data values are reported as mean±SE. Tested by the Wilcoxon signed-rank test (intragroup comparison) and by the Mann–Whitney test (intergroup comparison for initial value).

^†P<.1, ^*P<.05, ^**P<.01 compared with baseline in each group.

Glu, glucose; Glu_AUC, glucose area under curve.